Cezary Cybulski - Concepedia

Author

Cezary Cybulski

Also Known As

A Toloczko-Grabarek, Adam S Kibel, Anna Jakubowska, C Cybulski, C. Cybulski, Catriona McLean, Cezary CYBULSKI, Cezary Cybulski, Christiane Maier, Cybulski C

624

Publications

20.5K

Citations

H-Index

103

Concepts

All Affiliations

Pomeranian Medical University International Hereditary Cancer Center Women's College Hospital University of Toronto University of Cambridge

About

Cezary Cybulski is an author at Pomeranian Medical University specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	36	86	4.4K
2	Public Health	22	32	1.4K
3	Health Sciences	4	4	224
4	Engineering	3	3	113
5	Biology	2	2	57

Cezary Cybulski

206

Publications

12.6K

Citations

H-Index

Page 1

	Year	Citations
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk Ganna Chornokur, Hui‐Yi Lin, Jonathan P. Tyrer, PLoS ONE	2015	901
Impact of Oophorectomy on Cancer Incidence and Mortality in Women With a <i>BRCA1</i> or <i>BRCA2</i> Mutation Amy Finch, Jan Lubiński, Pål Møller, Journal of Clinical Oncology	2014	635
CHEK2 Is a Multiorgan Cancer Susceptibility Gene Cezary Cybulski, Bohdan Górski, Tomasz Huzarski, The American Journal of Human Genetics MedicinePathologyCancer BiologyCancer GeneticsOncology	2004	549
Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients Tomasz Byrski, Tomasz Huzarski, Rebecca Dent, Breast Cancer Research and Treatment	2008	339
Pathologic complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patients Tomasz Byrski, Tomasz Huzarski, R. Dent, Breast Cancer Research and Treatment Breast OncologyPathologic Complete ResponseMedicinePathologyImmune Checkpoint Inhibitor	2014	266
Association analyses identify 31 new risk loci for colorectal cancer susceptibility Philip Law, Maria Timofeeva, Ceres Fernández–Rozadilla, Nature Communications	2019	265
Risk of Breast Cancer in Women With a <i>CHEK2</i> Mutation With and Without a Family History of Breast Cancer Cezary Cybulski, Dominika Wokołorczyk, Anna Jakubowska, Journal of Clinical Oncology	2011	252
An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk Lang Wu, Yaohua Yang, Xingyi Guo, Nature Communications	2020	244
Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers Elizabeth Page, Elizabeth Bancroft, Mark N. Brook, European Urology	2019	231
Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts Tyler M. Seibert, Chun Chieh Fan, Yunpeng Wang, BMJ	2018	216

Page 1